In the carefully monitored confines of a clinical facility, patients with schizophrenia took what looked like an ordinary multivitamin. But inside each capsule was something that might soon change how ...
FDA clears path for Phase 3 testing following positive Type B meeting Regulatory alignment confirms preclinical data sufficient for pivotal ...
Doctors have been diagnosing schizophrenia for more than a hundred years, but when it comes to treating this serious brain illness, the remedies still fall short. Sure, they can treat the ...
Even so, the arrival of Cobenfy offers a new tool for treating schizophrenia — a disease with profound societal consequences, including homelessness and encounters with police — beyond a class of ...
Oral and parenteral antipsychotics show similar outcomes for patients with schizophrenia experiencing agitation in the ED, a ...
Schizophrenia is a chronic psychiatric disorder that requires lifelong management, with consistent medication adherence essential to prevent relapse and disability. Counseling that emphasizes empathy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback